Revolutionizing Pharmaceuticals

GSK is leveraging the vast amount of genetic data available today to enhance its pharmaceutical developments. With advancements in technologies like CRISPR, the ability to manipulate genes at a single-cell level opens new avenues for understanding diseases and creating targeted treatments. The evolution of these tools is transforming how the company approaches drug discovery and development.